Our Firm

Our Firm

Green Griffith is a preeminent intellectual property law firm, uniquely qualified to assist small and mid-sized pharmaceutical and biotech companies protect their most valuable assets and position them for future success.
Learn More >
Our Team

Our Team

Our technical knowledge makes the difference: all of our attorneys have degrees in pharma-related fields, including organic chemistry, chemical engineering and molecular biology, and many have advanced degrees.
Learn More >
Our Clients

Our Clients

Our clients are both generics and brand, small and mid-sized pharmaceutical and biotech companies, focused on securing market position and/or overcoming obstacles to new product entry for their drugs and therapies.​​
Learn More >

News and Insights

May 22, 2018

Patentability of All Challenged Claims Must be Decided if Inter Partes Review is Instituted

The U.S. Supreme Court overturned prior Patent Trial and Appeal Board (PTAB) practice, and requires a patentability determination to be reached f…
Read More >
May 21, 2018

Inter Partes Reviews Are Constitutional

The U.S. Supreme Court upheld the constitutionality of Inter Partes Review (IPR) patent validity proceedings before the Trial and Appeal Board (P…
Read More >
May 17, 2018

USPTO Issues Proposed Rules Changing Claim Construction Standard in Inter Partes Review

The proposal replaces the “broadest reasonable interpretation” standard for construing patent claims with a standard that is the sa…
Read More >
May 7, 2018

Robert Green Speaks at AIPPI Israel 2018 Convention

This unique event offered insight into the pivotal legal and business decisions faced by innovators and businesses on a daily basis, in the vario…
Read More >